These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38438418)

  • 21. Mother-to-Child HIV Transmission With In Utero Dolutegravir vs. Efavirenz in Botswana.
    Davey S; Ajibola G; Maswabi K; Sakoi M; Bennett K; Hughes MD; Isaacson A; Diseko M; Zash R; Batlang O; Moyo S; Lockman S; Lichterfeld M; Kuritzkes DR; Makhema J; Shapiro R
    J Acquir Immune Defic Syndr; 2020 Jul; 84(3):235-241. PubMed ID: 32195745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Highly Active Antiretroviral Therapy on Albuminuria in HIVinfected Persons.
    Adedeji TA; Adebisi SA; Adedeji NO
    Infect Disord Drug Targets; 2020; 20(3):374-384. PubMed ID: 31389318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.
    McComsey GA; Kitch D; Daar ES; Tierney C; Jahed NC; Tebas P; Myers L; Melbourne K; Ha B; Sax PE
    J Infect Dis; 2011 Jun; 203(12):1791-801. PubMed ID: 21606537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy, safety and central nervous system effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine.
    Nelson M; Winston A; Hill A; Mngqibisa R; Bassa A; Orkin C; Rassool M; Rodgers A; Teal V; Kumar S; Teppler H
    AIDS; 2021 Apr; 35(5):759-767. PubMed ID: 33587439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-state models for the analysis of time-to-treatment modification among HIV patients under highly active antiretroviral therapy in Southwest Ethiopia.
    Birlie B; Braekers R; Awoke T; Kasim A; Shkedy Z
    BMC Infect Dis; 2017 Jun; 17(1):453. PubMed ID: 28655306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body weight and blood pressure changes on dolutegravir-, efavirenz- or atazanavir-based antiretroviral therapy in Zimbabwe: a longitudinal study.
    Shamu T; Egger M; Mudzviti T; Chimbetete C; Manasa J; Anderegg N
    J Int AIDS Soc; 2024 Feb; 27(2):e26216. PubMed ID: 38332525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of mortality rate among adult HIV-positive patients on antiretroviral therapy in Metema Hospital, Northwest Ethiopia: a retrospective follow-up study.
    Workie KL; Birhan TY; Angaw DA
    AIDS Res Ther; 2021 May; 18(1):27. PubMed ID: 33952282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time to First Line Antiretroviral Therapy Adverse Drug Reaction and its Predictors Among Adult HIV/AIDS Patients on Treatment in Eastern Ethiopia.
    Weldesenbet AB; Tusa BS; Debele GR; Sisay MM; Ayele TA
    Front Pharmacol; 2022; 13():922744. PubMed ID: 36046817
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of different antiretroviral therapy on muscle mass, bone mineral density, and trabecular bone score in Chinese HIV-infected males.
    Zhang Z; Lin Q; Xu Y; Guan W; Song X; Li Y; Zhang Y; Li T; Yu W
    Arch Osteoporos; 2023 Apr; 18(1):48. PubMed ID: 37041320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of opportunistic infections and its predictors among HIV/AIDS patients on antiretroviral therapy in Gondar University Comprehensive and Specialized Hospital, Ethiopia.
    Dagnaw M; Fekadu H; Gebre Egziabher A; Yesfue T; Indracanti M; Tebeje A
    HIV Res Clin Pract; 2023 Mar; 24(1):2187013. PubMed ID: 36930750
    [No Abstract]   [Full Text] [Related]  

  • 31. Predictors of adverse drug reaction among adult HIV-infected patients on antiretroviral therapy in government hospitals of Kaffa Zone, Ethiopia; November 2018: a retrospective cohort.
    Mitkie AA; Bekele FB; Debiso AT
    Pan Afr Med J; 2021; 38():181. PubMed ID: 33995787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria.
    Eluwa GI; Badru T; Agu KA; Akpoigbe KJ; Chabikuli O; Hamelmann C
    BMC Clin Pharmacol; 2012 Feb; 12():7. PubMed ID: 22369677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss to follow-up in "test and treat era" and its predictors among HIV-positive adults receiving ART in Northwest Ethiopia: Institution-based cohort study.
    Bantie B; Seid A; Kerebeh G; Alebel A; Dessie G
    Front Public Health; 2022; 10():876430. PubMed ID: 36249247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-state Markov model for time to treatment changes for HIV/AIDS patients: a retrospective cohort national datasets, Ethiopia.
    Kumsa TH; Mulu A; Beyene J; Asfaw ZG
    BMC Infect Dis; 2024 Jun; 24(1):627. PubMed ID: 38914968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dolutegravir in real life: Self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho.
    Brown JA; Nsakala BL; Mokhele K; Rakuoane I; Muhairwe J; Glass TR; Amstutz A; Tschumi N; Belus JM; Klimkait T; Labhardt ND
    HIV Med; 2023 Feb; 24(2):153-162. PubMed ID: 35730213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Could a Dolutegravir-Based Antiretroviral Therapy Lead to Clinical Obesity? A Retrospective Cohort Study Conducted at Hawassa University Comprehensive Specialized Hospital in Hawassa, Sidama, Ethiopia.
    Eifa BA; Ketema W
    AIDS Res Treat; 2022; 2022():2965325. PubMed ID: 35603131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study.
    TenoRes Study Group
    Lancet Infect Dis; 2016 May; 16(5):565-575. PubMed ID: 26831472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired HIV drug resistance and virologic monitoring in a HIV hyper-endemic setting in KwaZulu-Natal Province, South Africa.
    Chimukangara B; Lessells RJ; Singh L; Grigalionyte I; Yende-Zuma N; Adams R; Dawood H; Dlamini L; Buthelezi S; Chetty S; Diallo K; Duffus WA; Mogashoa M; Hagen MB; Giandhari J; de Oliveira T; Moodley P; Padayatchi N; Naidoo K
    AIDS Res Ther; 2021 Oct; 18(1):74. PubMed ID: 34656129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in nutritional, functional and immunological status of HIV-infected adults with antiretroviral therapy.
    Tafese Z; Berhan Y; Abebe H
    Ethiop Med J; 2012 Jan; 50(1):75-87. PubMed ID: 22519164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia.
    Ayele G; Tessema B; Amsalu A; Ferede G; Yismaw G
    BMC Immunol; 2018 Dec; 19(1):37. PubMed ID: 30558580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.